O43924 (PDE6D_HUMAN) Homo sapiens (Human)

Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta UniProtKBProtein AtlasInterProSTRINGInteractive Modelling

150 aa; Sequence (Fasta) ; 11 identical sequences

Available Structures

35 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Crystal structure of full-length farnesylated and methylated KRAS4b in complex with PDE-delta (crys… Heteromer
P01116;
1-150
100FAR;GDP;EDO;
Crystal structure of the high affinity KRas mutant PDE6D complex Heteromer
P01116;
1-150
100GDP;FAR;SO4;EDO;
Complex of Arl2 and PDE delta, Crystal Form 2 (native) Heteromer
Q9D0J4;
2-150
100.0MG;PO4;GDP;
Complex of Arl2 and PDE delta, Crystal Form 2 (SeMet) Heteromer
Q9D0J4;
2-150
100.0PO4;MG;BME;GDP;GTP;
Crystal structure of farnesylated and methylated kras4b in complex with PDE-delta (crystal form II … Heteromer
P01116;
3-150
100FAR;GDP;EDO;
Structure of fully modified farnesylated Rheb in complex with PDE6D Heteromer
Q15382;
4-150
100GDP;MG;FAR;
The crystal structure of the RPGR RCC1-like domain in complex with PDE6D Heteromer
Q92834;
4-150
100.0
Structure of Fully modified geranylgeranylated PDE6C Peptide in complex with PDE6D Heteromer
P51160;
4-150
100GER;
Complex of Arl2 and PDE delta, Crystal Form 1 Heteromer
Q9D0J4;
4-150
100.0MG;GTP;
The crystal Structure PDE delta in complex with (rac)-p9monomer1-150
100.0P59;P69;
The crystal structure of inhibitor-15 covalently bound to PDE6Dmonomer1-150
1008RQ;
The crystal Structure PDE delta in complex with compound (R, R)-1gmonomer1-150
99.33JAY;
Cocrystal structure of PDE6D bound to NRAS peptidemonomer1-150
100.0FAR;EDO;SO4;
The crystal Structure PDE delta in complex with R-p9monomer1-150
100.0P59;
Crystal structure of PDE6D in complex with Compound-2monomer1-150
100.0EDO;9VO;SO4;
The crystal structure of PDE6D in complex to Deltasonamide1monomer2-150
100DL3;
The crystal structure of PDE6D in complex with rac-S1monomer2-150
100.01M1;
Crystal structure of PDE6D Geranylgeranylated cystein complexmonomer2-150
100.0CMT;EDO;GER;
The crystal structure of DW-0254 in complex with PDE6Dmonomer2-150
100NI;GOL;O7W;EPE;
The crystal structure of PDE6D in complex with inhibitor-3monomer2-150
100.0NH6;
Crystal structure of PDE6D in complex with the inhibitor rac-2monomer2-150
100.01M0;
The crystal structure of Deltarasin in complex with PDE6Dmonomer2-150
100O7T;ACY;
Crystal structure of PDE6D KRas peptide complex with Compound-1monomer2-150
1009TI;SO4;EDO;FAR;
Structure of Fully modified farnesylated INPP5E Peptide in complex with PDE6Dmonomer2-150
100FAR;
The crystal structure of PDE6D in complex to inhibitor-1monomer2-150
100.018F;
The crystal structure of PDE6D in complex to inhibitor-8monomer2-150
100.09GD;
Crystal structure of PDE6D bound to HRas peptidemonomer2-150
100FAR;CMT;EDO;
Fragment-based Drug Discovery of inhibitors to block PDEdelta-RAS protein-protein interactionmonomer2-150
100.08SF;
Fragment-based Drug Discovery of inhibitors to block PDEdelta-RAS protein-protein interactionmonomer2-150
100.08SL;
The crystal structure of PDE6D in the apo statemonomer2-150
100NI;EPE;
Structure of Fully modified farnesylated Rheb Peptide in complex with PDE6Dmonomer2-150
100FAR;
The crystal structure of PDE6D in complex to inhibitor-7monomer2-150
100RRQ;
The crystal structure of PDEd in complex with inhibitor-2amonomer2-150
99.335KP;
The crystal structure of PDE6D in complex to inhibitor-4monomer2-150
100.0V98;
The Crystal structure of PDE6D in complex with the inhibitor (s)-5monomer4-150
100.017X;

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
5tb5.1.Bmonomer0.861-150
100.00